Inhalation Sciences: close to 200 register for latest expert’s webinar - now available online
(Stockholm, Sweden, 4 May 2023) Almost 200 specialists registered for ISAB’s latest experts’ webinar, now available to view online on ISAB’s LinkedIn page. The webinar was co-hosted by ISAB CSO Per Gerde and Matt Reed from Coelus Bio. It demonstrated how high-precision preclinical in vivo data can provide more accurate clinical estimates that reduce risk in the clinical development of inhaled medicines.
The webinar took place on May 2nd, 2023. It was co-hosted by Matt Reed from Coelus Bio - a pharmacologist and board-certified toxicologist with over 25 years’ experience. The webinar was the latest in an ongoing series from Inhalation Sciences AB which is receiving positive industry interest.
ISAB offers a competitive range of in vivo testing solutions, including its intratracheal module that uses a catheter connected to PreciseInhale to bypass the nasal airways, ensuring test substances are retained in the lung and delivering high-precision data with, typically, <10% Standard Deviation.
CEO Manoush Masarrat: “These webinars are an excellent showcase of our capabilities. We’re delighted so many took part! Our inhalation research services (IRS) are a vital growth driver for us, sharing our knowledge and capabilities at these events builds partnerships and ultimately sales.”
Watch the webinar here.
For more information about Inhalation Sciences, please contact:
Manoush Masarrat, CEO
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153
About Inhalation Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define
Tags: